EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay Pharmaceuticals will hold its third quarter 2015 investment community conference call on November 16 at 8:30 a.m. ET
Gaucher disease may protect against Parkinson’s disease-related color visual impairment
Parkinson’s Disease (PD) patients have a five-fold greater risk of carrying genetic mutations in the β-glucocerebrosidase gene (GBA), which are commonly associated with Gaucher disease (GD).
Uncategorized
Ophthotech reports $39.6 million net loss in third quarter
Ophthotech reported a net loss of $39.6 million, or $1.14 per diluted share, in the third quarter compared with a net income of $8.6 million, or $0.25 per diluted share, in the third quarter of 2014, according to a press release. The 2014 income was at…
Ocular Therapeutix™ Reports Third Quarter 2015 Financial Results
BEDFORD, Mass.–(BUSINESS WIRE)–Ocular Therapeutix™, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye, today announced financial results for the third quarter ended September 30, 2015. “Our product development programs advanced meaningfully during the third quarter with an NDA submission to the Food and Drug Administration for our lead product candidate, DEXTENZA for a post-surgical o
Glaukos Corporation Announces Third Quarter 2015 Financial Results
LAGUNA HILLS, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma, …
Purple Button mobile app helps HMC achieve overall goal of improving patient safety, quality
CRG Medical officially announced today the implementation of the ONC for IT award winning Purple Button mobile patient safety application at HMC. The Purple Button, powered by CRG Medical, supports the KB Core High Reliability Patient Safety Evaluation…